The isotopes-and-materials rung held while the quantum pure-plays sold off, extending Friday's AI-valuation jitters into the names with the thinnest cash flows.

Silex Systems' US line (SILXY) led the vertical, up 4.0% to $15.12, on no fresh company disclosure — a materials name holding firm while the computing pure-plays bled. Silex owns the isotopes-materials chokepoint directly: its Zero-Spin Silicon project with Silicon Quantum Computing uses SILEX laser separation to strip spin-carrying Si-29 below 100 ppm, the feedstock constraint for silicon-spin qubit roadmaps. As an ADR of the Australian listing, read the move as that name's last session rather than a US-hours catalyst, and note the pick-and-shovel rung's relative strength is the real signal — ASP Isotopes (ASPI) edged up 0.7% to $2.93 with its first commercial silicon-28 shipments still guided for Q3.

The laggard was Arqit Quantum (ARQQ), down 3.8% to $23.68, leading the pure-play selloff. Arqit is not a quantum-computer maker — it is a post-quantum-encryption vendor whose narrative reprices with the same quantum tape — so its slide is a clean read on sentiment, not fundamentals. The computing names followed: Quantum Computing Inc. (QUBT) −2.9% to $7.94, IonQ (IONQ) −1.8% to $42.97, Rigetti (RGTI) −0.7% and D-Wave (QBTS) −0.8%. The group gave back as Friday's AI-valuation worries carried into the session's highest-beta, cash-light rung.

Breadth split cleanly along the supply chain. The instruments and materials layer was green — Agilent (A) +2.1% to $171.29, VAT Group's US line (VACNY) +1.5% on the ultra-high-vacuum rung, Bruker (BRKR) +1.0%, Applied Materials (AMAT) +0.4% — while foundry and logic exposure was heavy: GlobalFoundries (GFS) −3.2% to $48.56 and Intel (INTC) −2.6% to $116.19. The message of the tape was a rotation out of the quantum story and into the arms dealers who sell into it regardless of which modality wins.

The forward calendar is where the hard catalysts sit. The DARPA Quantum Benchmarking Initiative runs its Stage B-to-Stage C downselect window from early November into mid-December — the capital-allocation signal the pure-plays trade on. Q2B26 Chicago (Dec 8–10) is the next industry venue, and Senate floor action on the National Quantum Initiative Reauthorization Act (S.3597) is expected around December 18. Nearer term, ASP Isotopes' first commercial silicon-28 shipments, guided to Q3, are the concrete milestone on the isotopes-materials choke that led today — a deliverable, not a narrative.